- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor Which conditions qualify? The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis in America Medical Cannabis Access for Pain Treatment
- Join Join
State of the States - 2016
This annual report evaluates the array of differing state medical cannabis programs across the country from a perspective often overlooked in policy debates - the patients - and provides policy makers with model legislation and regulations. With dozens of states already seeing legislative and regulatory proposals in 2016, this groundbreaking report will provide state lawmakers with timely tools they need to improve their medical cannabis programs to truly meet the needs of the patients they are meant to serve.
This report comes at a perfect time to inform improvements to existing medical marijuana programs and guide legislators who are creating or expanding laws and programs. “Too often, patients are denied life-saving treatments solely because they are using medical cannabis,” said California Assemblymember Marc Levine, champion of the Medical Cannabis Organ Transplant Act (AB 258), “It is imperative for state lawmakers to take advantage of vital resources like ASA’s report to improve their state programs.”
The report uses a point system to grade each medical marijuana law on:
- Patients' rights and protection from discrimination
- Access to medicine
- Ease of navigation
- Product safety protocols
The report found that while many states have important elements helpful to patients, no state has yet established an ideal, comprehensive program.
Letter-grades for all 23 state laws and Washington, D.C.: Alaska (D-), Arizona (B-), California (B+), Colorado (B), Connecticut (C+), Delaware (C), Hawaii (B), Georgia (F), Illinois (B+), Iowa (F), Louisiana (F), Maine (B-), Maryland (B), Massachusetts (B), Michigan (D+), Minnesota (C), Montana (D-), Nevada (B), New Hampshire (C), New Jersey (C), New Mexico (B+), New York (C), Oregon (B), Rhode Island (C-), Vermont (D+), Washington (B), and the District of Columbia (C).
Medical Marijuana Access in the U.S. One Pager
Watch our Live Questions and Answers Hangout about the Report
Take Action To Share This Report With Your Representatives
Download the 2016 Access Report